Unknown

Dataset Information

0

Exploiting base excision repair to improve therapeutic approaches for pancreatic cancer.


ABSTRACT: Pancreatic ductal adenocarcinoma (PDA) is a highly chemoresistant and metastatic disease with a dismal 5-year survival rate of 6%. More effective therapeutic targets and approaches are urgently needed to tackle this devastating disease. The base excision repair (BER) pathway has been identified as a predictor of therapeutic response, prognostic factor, and therapeutic target in a variety of cancers. This review will discuss our current understanding of BER in PDA and its potential to improve PDA treatment.

SUBMITTER: Sharbeen G 

PROVIDER: S-EPMC4428371 | biostudies-literature | 2015

REPOSITORIES: biostudies-literature

altmetric image

Publications

Exploiting base excision repair to improve therapeutic approaches for pancreatic cancer.

Sharbeen George G   McCarroll Joshua J   Goldstein David D   Phillips Phoebe A PA  

Frontiers in nutrition 20150327


Pancreatic ductal adenocarcinoma (PDA) is a highly chemoresistant and metastatic disease with a dismal 5-year survival rate of 6%. More effective therapeutic targets and approaches are urgently needed to tackle this devastating disease. The base excision repair (BER) pathway has been identified as a predictor of therapeutic response, prognostic factor, and therapeutic target in a variety of cancers. This review will discuss our current understanding of BER in PDA and its potential to improve PDA  ...[more]

Similar Datasets

| S-EPMC5859333 | biostudies-literature
| S-EPMC8956022 | biostudies-literature
| S-EPMC3798558 | biostudies-literature
| S-EPMC3683898 | biostudies-literature
| S-EPMC5689576 | biostudies-literature
| S-EPMC4546830 | biostudies-literature
| S-EPMC6340775 | biostudies-literature
| S-EPMC4658501 | biostudies-literature
| S-EPMC3307187 | biostudies-literature
| S-EPMC4964126 | biostudies-literature